Jean-Cosme Dodart is senior vice president of preclinical R&D at Vaxxinity. Dr. Dodart brings to Vaxxinity over 20 years of experience in neuroscience drug development at both large pharmaceutical companies (Lilly, Merck, Novartis) and small biotech companies (Sage Therapeutics, Wave Life Sciences). He has a strong track record ofsuccess in drug discovery and has worked in many disorders affecting the nervous system, including Alzheimer’s disease, Parkinson’s disease, neuromuscular disorders, pain and depression. Many of the pre-clinical projects that Dr. Dodart has persued have made it into clinical testing including several promising drug candidates that are currently in clinical trials. Dr. Dodart earned his MS degree in cell biology and physiology from the University Pierre and Marie Curie in Paris and his PhD in neuroscience from the University Louis Pasteur in Strasbourg, France.